Holen Sie sich die Stockscreener-App
15.60
0.32%
0.05
Handel nachbörslich:
15.60
Finanzdaten der Denali Therapeutics Inc-Aktie (DNLI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 14.54 |
Operating Expenses
|
7.29%
134.96
|
145.58 | 123.19 | 116.59 | 132.25 |
| Operating Income/Loss |
7.29%
-134.96
|
-145.58 | -123.19 | -116.59 | -117.72 |
| Income/Loss From Continuing Operations Before Tax |
6.66%
-124.12
|
-132.97 | -107.19 | -99.03 | -101.80 |
| Income/Loss From Continuing Operations After Tax |
6.66%
-124.12
|
-132.97 | -107.19 | -99.03 | -101.80 |
|
Net Income/Loss
|
6.66%
-124.12
|
-132.97 | -107.19 | -99.03 | -101.80 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.13%
171.45
|
171.22 | 169.46 | 168.83 | 149.40 |
| Diluted Average Shares |
0.13%
171.45
|
171.22 | 169.46 | 168.83 | 149.40 |
| Basic Earnings Per Share |
7.69%
-0.72
|
-0.78 | -0.63 | -0.59 | -0.68 |
| Diluted Earnings Per Share |
7.69%
-0.72
|
-0.78 | -0.63 | -0.59 | -0.68 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):